Assessment of global cardiac I-123 MIBG uptake and washout using volumetric quantification of SPECT acquisitions

Journal of Nuclear Cardiology

Volumn 19, Issue 4, 2012, Pages 752-762

  Van Der Veen, Berlinda J ^a   Al Younis, Imad ^a   De Roos, Albert ^a   Stokkel, Marcel P M ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

I 123 meta iodobenzylguanidine; Myocardial innervation; Quantitative analysis; SPECT

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; POTASSIUM IODIDE; SODIUM IODIDE;

ADULT; AGED; ARTICLE; CARDIAC LUMEN; DRUG UPTAKE; FEMALE; HEART; HEART LEFT VENTRICLE; HEART MUSCLE; HUMAN; IMAGE ANALYSIS; LIVER; LUNG; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM; MYOCARDIAL WALL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VOLUMETRY;

3-IODOBENZYLGUANIDINE; AGE FACTORS; AGED; FEMALE; HEART; HEART VENTRICLES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IODINE RADIOISOTOPES; MALE; MEDIASTINUM; MIDDLE AGED; MYOCARDIUM; OBSERVER VARIATION; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84865073819     PISSN: 10713581     EISSN: 15326551     Source Type: Journal    
DOI: 10.1007/s12350-012-9539-4     Document Type: Article

References (33)

1. Carrio I. Cardiac neurotransmission imaging. J Nucl Med 2001;42:1062-76.
2. Ji SY, Travin MI. Radionuclide imaging of cardiac autonomic innervation. J Nucl Cardiol 2010;17:655-66.
3. Henneman MM, Bengel FM, van der Wall EE, Knuuti J, Bax JJ. Cardiac neuronal imaging: application in the evaluation of cardiac disease. J Nucl Cardiol 2008;15:442-55.
4. Yamashina S, Yamazaki J. Neuronal imaging using SPECT. Eur J Nucl Med Mol Imaging 2007;34:939-50.
5. Flotats A, Carrio I, Agostini D, et al. Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology. Eur J Nucl Med Mol Imaging 2010;37:1802-12.
6. Somsen GA, Verberne HJ, Fleury E, Righetti A. Normal values and within-subject variability of cardiac I-123 MIBG scintigraphy in healthy individuals: implications for clinical studies. J Nucl Cardiol 2004;11:126-33.
7. Muxi A, Paredes P, Navales I, et al. Diagnostic cutoff points for (1)(2)(3)I-MIBG myocardial scintigraphy in a Caucasian population with Parkinson's disease. Eur J Nucl Med Mol Imaging 2011;38:1139-46.
8. Hattori N, Tamaki N, Hayashi T, et al. Regional abnormality of iodine-123-MIBG in diabetic hearts. J Nucl Med 1996;37:1985-90.
9. Flotats A, Carrio I. Cardiac neurotransmission SPECT imaging. J Nucl Cardiol 2004;11:587-602.
10. Boogers MJ, Borleffs CJ, Henneman MM, et al. Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients. J Am Coll Cardiol 2010;55:2769-77.
11. Matsunari I, Aoki H, Nomura Y, et al. Iodine-123 metaiodobenzylguanidine imaging and carbon-11 hydroxyephedrine positron emission tomography compared in patients with left ventricular dysfunction. Circ Cardiovasc Imaging 2010;3:595-603.
12. Simoes MV, Barthel P, Matsunari I, et al. Presence of sympathetically denervated but viable myocardium and its electrophysiologic correlates after early revascularised, acute myocardial infarction. Eur Heart J 2004;25:551-7.
13. Tsuchimochi S, Tamaki N, Tadamura E, et al. Age and gender differences in normal myocardial adrenergic neuronal function evaluated by iodine-123-MIBG imaging. J Nucl Med 1995;36: 969-74.
14. Chinn S. Statistics in respiratory medicine 2. Repeatability and method comparison. Thorax 1991;46:454-6.
15. Bruton A, Conway JH, Holgate ST. Reliability: What is it, and how is it measured? Physiotherapy 2000;86:94-9.
16. McGraw KO, Wong SP. Forming inferences about some intraclass correlation coefficients. Psychol Methods 1996;1:30-46.
17. Verberne HJ, Somsen GA, Povinec P, van Eck-Smit BL, Jacobson AF. Impact of mediastinal, liver and lung (123)Imetaiodobenzylguanidine ((123)I-MIBG) washout on calculated (123)I-MIBG myocardial washout. Eur J Nucl Med Mol Imaging 2009;36:1322-8.
18. Gill JS, Hunter GJ, Gane G, Camm AJ. Heterogeneity of the human myocardial sympathetic innervation: In vivo demonstration by iodine 123-labeled meta-iodobenzylguanidine scintigraphy. Am Heart J 1993;126:390-8.
19. Somsen GA, Borm JJ, de Milliano PA, van Vlies B, Dubois EA, van Royen EA. Quantitation of myocardial iodine-123 MIBG uptake in SPET studies: A new approach using the left ventricular cavity and a blood sample as a reference. Eur J Nucl Med 1995;22:1149-54.
20. Verberne HJ, Verschure DO, Somsen GA, van Eck-Smit BL, Jacobson AF. Vascular time-activity variation in patients undergoing (1)(2)(3)I-MIBG myocardial scintigraphy: Implications for quantification of cardiac and mediastinal uptake. Eur J Nucl Med Mol Imaging 2011;38:1132-8.
21. Druschky A, Hilz MJ, Platsch G, et al. Differentiation of Parkinson's disease and multiple system atrophy in early disease stages by means of I-123-MIBG-SPECT. J Neurol Sci 2000;175:3-12.
22. Simula S, Vanninen E, Viitanen L, et al. Cardiac adrenergic innervation is affected in asymptomatic subjects with very early stage of coronary artery disease. J Nucl Med 2002;43:1-7.
23. Wakabayashi T, Nakata T, Hashimoto A, et al. Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death. J Nucl Med 2001;42:1757-67.
24. Yukinaka M, Nomura M, Ito S, Nakaya Y. Mismatch between myocardial accumulation of 123I-MIBG and 99mTc-MIBI and late ventricular potentials in patients after myocardial infarction: Association with the development of ventricular arrhythmias. Am Heart J 1998;136:859-67.
25. Fallavollita JA, Canty JM Jr. Dysinnervated but viable myocardium in ischemic heart disease. J Nucl Cardiol 2010;17:1107-15.
26. Sakata K, Iida K, Kudo M, Yoshida H, Dog O. Prognostic value of I-123 metaiodobenzylguanidine imaging in vasospastic angina without significant coronary stenosis. Circ J 2005;69:171-6.
27. Chen LS, Zhou S, Fishbein MC, Chen PS. New perspectives on the role of autonomic nervous system in the genesis of arrhythmias. J Cardiovasc Electrophysiol 2007;18:123-7.
28. Nishisato K, Hashimoto A, Nakata T, et al. Impaired cardiac sympathetic innervation and myocardial perfusion are related to lethal arrhythmia: quantification of cardiac tracers in patients with ICDs. J Nucl Med 2010;51:1241-9.
29. Stevens MJ, Raffel DM, Allman KC, et al. Cardiac sympathetic dysinnervation in diabetes: Implications for enhanced cardiovascular risk. Circulation 1998;98:961-8.
30. Nagamachi S, Fujita S, Nishii R, et al. Prognostic value of cardiac I-123 metaiodobenzylguanidine imaging in patients with noninsulin- dependent diabetes mellitus. J Nucl Cardiol 2006;13:34-42.
31. Scholte AJ, Schuijf JD, Delgado V, et al. Cardiac autonomic neuropathy in patients with diabetes and no symptoms of coronary artery disease: comparison of 123I-metaiodobenzylguanidine myocardial scintigraphy and heart rate variability. Eur J Nucl Med Mol Imaging 2010;37:1698-705.
32. Vinik AI, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation 2007;115:387-97.
33. Bengel FM, Schwaiger M. Assessment of cardiac sympathetic neuronal function using PET imaging. J Nucl Cardiol 2004;11: 603-16.